In a significant medical feat, Indian scientists have developed the first-in-human gene therapy using lentiviral vectors for ...

In the groundbreaking study the researchers observed an annualised zero bleeding rate in all the five subjects enrolled with ...

Current treatments require frequent Factor VIII replacement therapy, which faces challenges such as high costs, venous access ...

Haemophilia is a severe bleeding disorder caused by the deficiency of clotting Factor VIII, leading to spontaneous internal ...

BHUBANESWAR: In a significant medical breakthrough, India's first human gene therapy with a lentiviral vector for severe ...

India has successfully conducted its first in-human gene therapy for hemophilia A, with patients experiencing no bleeding ...

Researchers suggest an application to FDA may be made within the next 12 months, requesting approval to carry out a human clinical trial with the gene therapy.

Can you stop LCA, a form of blindness caused by a change in a single base pair, simply by injecting a viral vector with the ... and doctors planning human gene therapy trials for LCA.

New data publishing 11/11 in Cell Stem Cell provides strong support for the first-in-human universal gene therapy trial ... genetic mutations with a single vector. This clinical-grade vector ...

A recent study published in the journal Human Gene Therapy evaluated the long-term survival and cardiac efficacy of the gene ...